| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0088 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |